Package 63323-881-16

Brand: sodium phosphates

Generic: sodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic, anhydrous
NDC Package

Package Facts

Identity

Package NDC 63323-881-16
Digits Only 6332388116
Product NDC 63323-881
Description

25 VIAL, SINGLE-DOSE in 1 TRAY (63323-881-16) / 15 mL in 1 VIAL, SINGLE-DOSE (63323-881-01)

Marketing

Marketing Status
Marketed Since 2022-03-30
Brand sodium phosphates
Generic sodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic, anhydrous
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "3ae3c9a3-3503-4264-8c77-00089f50cc74", "openfda": {"unii": ["22ADO53M6F", "593YOG76RN"], "rxcui": ["1872384", "1872443", "1872447"], "spl_set_id": ["5bf47be3-f3fe-452b-8113-941796498345"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL, SINGLE-DOSE in 1 TRAY (63323-881-16)  / 15 mL in 1 VIAL, SINGLE-DOSE (63323-881-01)", "package_ndc": "63323-881-16", "marketing_start_date": "20220330"}], "brand_name": "Sodium Phosphates", "product_id": "63323-881_3ae3c9a3-3503-4264-8c77-00089f50cc74", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Increased Large Intestinal Motility [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Osmotic Activity [MoA]", "Osmotic Laxative [EPC]"], "product_ndc": "63323-881", "generic_name": "sodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic, anhydrous", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Sodium Phosphates", "active_ingredients": [{"name": "SODIUM PHOSPHATE, DIBASIC, ANHYDROUS", "strength": "142 mg/mL"}, {"name": "SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE", "strength": "276 mg/mL"}], "application_number": "ANDA209997", "marketing_category": "ANDA", "marketing_start_date": "20220330", "listing_expiration_date": "20261231"}